Keyphrases
Clinical Trials
100%
Predictive Biomarker
100%
In Cancer
100%
Cancer Immunotherapy
100%
Clinical Benefit
50%
Malignancy
50%
Clinical Efficacy
50%
Histology
50%
Treatment Regimen
50%
Patients with Cancer
50%
Randomized Clinical Trial
50%
Adverse Effects
50%
Stool
50%
Treatment Standards
50%
Immune Toxicity
50%
Immune Checkpoint Inhibitors
50%
Archival Tissue
50%
High Cost
50%
Medical Oncology
50%
Biomarker Studies
50%
Immunotherapy Agents
50%
High Standards
50%
Specific Point
50%
Social Needs
50%
Prospective Planning
50%
Medicine and Dentistry
Biological Marker
100%
Immunotherapy
100%
Cancer Immunotherapy
100%
Clinical Trial
50%
Cancer
25%
Health Care Cost
25%
Side Effect
25%
Randomized Clinical Trial
25%
Medical Oncology
25%
Biomarker Study
25%
Immunity
25%
Immune Checkpoint Inhibitor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Biological Marker
100%
Immunotherapy
100%
Clinical Trial
40%
Side Effect
20%
Randomized Clinical Trial
20%
Biomarker Study
20%
Immune Checkpoint Inhibitor
20%
Immunology and Microbiology
Immunotherapy
100%
Cancer Immunotherapy
100%
Immunity
50%
Solution and Solubility
25%
Blood Plasma
25%
Neuroscience
Immunotherapy
100%
Cancer Immunotherapy
100%
Blood Plasma
25%